Skip to main content

Table 1 Sample summary table presented in survey showing select results from overview of reviews on bronchiolitis

From: An evaluation of harvest plots to display results of meta-analyses in overviews of reviews: a cross-sectional study

Bronchiolitis - inpatient outcomes

Clinical score

Length of stay

Time point for clinical score assessment

Patients (studies)

Effect estimate SMD (95 % CI)

I2 (%)

Quality of evidence

Patients (studies)

Effect estimate MD (95 % CI)

I2 (%)

Quality of evidence

Glucocorticoids vs. placebo

 At 1–3 days

113 (4)

−0.74 (−1.48,1.01)

70

Low

633 (8)

−0.18 (−0.39,0.04)

16

High

Bronchodilator vs. placebo

 No data

349 (6)

0.06 (−0.27,0.39)

0

Moderate

Epinephrine vs. placebo

 At 60 min

232 (2)

−0.04 (−0.49, 0.40)

46

Moderate

292 (2)

−0.35 (−0.87,0.17)

0

Moderate

Epinephrine vs. bronchodilator

 At 60 min

248 (4)

−0.79 (−1.45,-0.13) a

79

Low

261 (4)

−0.28 (−0.46,-0.09) a

0

Moderate

 At 120 min

140 (1)

−0.52 (−0.68,-0.18) a

NA

Low

3 % hypertonic saline vs. 0.9 % saline

 At 1–3 days

183 (3)

−0.84 (−1.39,-0.30)

66

Low

282 (4)

−1.16 (−1.55,-0.77) a

0

Moderate

 At 3–10 days

156 (3)

−1.08 (−2.47,0.31)

93

Moderate

Chest physiotherapy vs. standard care or other drainage/breathing technique

 At 1–3 days

87 (1)

−0.55 (−0.98,-0.12) a

NA

Low

172 (3)

0.07 (−0.58,0.73)

0

Low

 At 3–10 days

91 (2)

−0.14 (−0.81,0.53)

59

Low

  1. afavours 1st intervention; NA - not applicable; SMD - standardized mean difference
  2. Outcomes in bold indicate statistical significance